GlassScriptPhysician profile
John W Richard
NPI 1124047717
$225,726.47
in general payments reported to CMS, 2019-2025
100 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $15K · 2021: $30K · 2022: $21K · 2023: $21K · 2024: $35K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Debt Forgiveness: $34K · Food and Beverage: $22K · Travel and Lodging: $2,249 · Education: $260 · Entertainment: $15.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,850.00 |
| Debt Forgiveness | $33,600.00 |
| Food and Beverage | $21,878.30 |
| Travel and Lodging | $2,248.95 |
| Education | $259.91 |
| Entertainment | $15.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $50,129.56 | 2019-2025 | Repatha, Repatha, Otezla |
| Esperion Therapeutics, INC. | $40,496.73 | 2020-2025 | Nexletol, Nexlizet |
| Convatec INC. | $33,725.09 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $27,994.57 | 2019-2023 | Spravato, Xarelto |
| Sanofi-Aventis U.S. LLC | $16,482.65 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,471.83 | 2019-2025 | Xifaxan, Relistor |
| Paratek Pharmaceuticals, INC. | $4,925.00 | 2021-2025 | Nuzyra |
| Sunovion Pharmaceuticals INC. | $3,866.96 | 2019-2022 | |
| Abbvie INC. | $3,665.54 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $3,246.33 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Novo Nordisk INC | $2,985.97 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $2,439.72 | 2019-2025 | Airsupra, Farxiga, Flumist Quadrivalent |
| Teva Pharmaceuticals USA, INC. | $2,260.91 | 2019-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Pfizer INC. | $2,146.37 | 2019-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $2,141.02 | 2020-2025 | Caplyta |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,576.01 | 2020-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Vanda Pharmaceuticals INC. | $1,198.50 | 2020-2025 | Fanapt, Hetlioz |
| Bayer Healthcare Pharmaceuticals INC. | $1,125.30 | 2021-2025 | |
| Astellas Pharma US INC | $1,052.23 | 2019-2024 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $1,022.39 | 2019-2025 | |
| Axsome Therapeutics, INC. | $979.89 | 2023-2025 | Auvelity, Sunosi, Symbravo |
| Neurocrine Biosciences, INC. | $946.90 | 2019-2025 | Ingrezza |
| Xeris Pharmaceuticals, INC. | $858.03 | 2021-2023 | Gvoke Hypopen |
| Romark Laboratories, Lc | $709.52 | 2019-2020 | |
| Allergan, INC. | $696.36 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $683.08 | 2023-2025 | Gemtesa, Aptiom |
| Phathom Pharmaceuticals, INC. | $649.03 | 2024-2025 | Voquezna |
| Genentech USA, INC. | $638.24 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $607.32 | 2022 | |
| Ucb, INC. | $579.13 | 2022-2025 | Nayzilam, Briviact |
| Merck Sharp & Dohme LLC | $576.73 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Biohaven Pharmaceuticals, INC. | $543.04 | 2021 | |
| Janssen Biotech, INC. | $471.49 | 2023-2025 | Tremfya, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $437.12 | 2019-2022 | |
| Amarin Pharma, INC. | $401.15 | 2019-2020 | |
| Lilly USA, LLC | $400.69 | 2020-2024 | Mounjaro, Zepbound |
| Corium, LLC | $396.44 | 2022-2024 | Azstarys |
| Sun Pharmaceutical Industries INC. | $371.69 | 2020-2022 | |
| Upsher-Smith Laboratories LLC | $354.32 | 2019-2022 | |
| Abbott Laboratories | $322.08 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.55 | 2019-2023 | Ofev, Jardiance |
| Lundbeck LLC | $278.26 | 2021-2025 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $246.36 | 2023-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $217.73 | 2019-2025 | Cobenfy, Eliquis |
| Antares Pharma, INC. | $205.90 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Dexcom, INC. | $189.26 | 2024-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $132.01 | 2019-2021 | |
| Revance Therapeutics, INC. | $130.54 | 2024-2025 | Daxxify |
| Horizon Therapeutics Plc | $129.09 | 2019-2022 | |
| Shield Therapeutics INC | $125.91 | 2024 | |
| Bioventus LLC | $112.98 | 2020-2022 | |
| Bausch Health US, LLC | $109.37 | 2021-2025 | Aplenzin, Wellbutrin |
| Acadia Pharmaceuticals INC | $102.80 | 2020-2024 | Nuplazid |
| Urgo Medical North America, LLC | $101.90 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Medtronic, INC. | $90.83 | 2022 | |
| Corcept Therapeutics | $85.19 | 2023-2025 | Korlym |
| Eisai INC. | $78.68 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $77.04 | 2021-2025 | Seglentis, Zoryve |
| Tandem Diabetes Care, INC. | $72.92 | 2019 | |
| Impel Pharmaceuticals INC. | $65.90 | 2023 | Trudhesa |
| Vertos Medical, INC. | $63.58 | 2019 | |
| Scilex Pharmaceuticals INC. | $60.54 | 2019-2020 | |
| Insulet Corporation | $56.59 | 2025 | Omnipod |
| Jazz Pharmaceuticals INC. | $55.72 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $51.41 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $50.86 | 2023-2024 | Cologuard Collection Kit |
| Kerecis Limited | $49.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cipher Pharmaceuticals US LLC | $48.99 | 2025 | Natroba, Spinosad |
| Circassia INC. | $48.50 | 2019-2020 | |
| Genentech, INC. | $45.66 | 2019 | |
| Nestle Healthcare Nutrition INC. | $45.01 | 2021-2022 | |
| Halozyme INC | $44.63 | 2023 | |
| Clarus Therapeutics INC. | $43.08 | 2021 | |
| Lucid Diagnostics INC. | $43.00 | 2022 | |
| Organogenesis INC. | $38.12 | 2023 | Puraply |
| Impel Pharmaceuticals LLC | $35.30 | 2025 | Trudhesa |
| Smith+Nephew, INC. | $29.92 | 2020-2025 | Collagenase Santyl |
| Boston Scientific Corporation | $29.85 | 2022-2023 | |
| Mdd US Operations, LLC | $28.51 | 2019-2020 | |
| Indivior INC. | $27.16 | 2020-2022 | |
| Tonix Medicines, INC. | $24.54 | 2025 | Tonmya |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $22.54 | 2025 | Rejoyn |
| Verona Pharma, INC. | $22.54 | 2025 | Ohtuvayre |
| Abiomed | $21.20 | 2024 | Impella |
| Beta Bionics, INC. | $20.92 | 2024 | Ilet Bionic Pancreas |
| Almatica Pharma LLC | $20.87 | 2025 | Loreev Xr |
| Ultragenyx Pharmaceutical INC. | $20.01 | 2023 | |
| Alnylam Pharmaceuticals INC. | $18.81 | 2025 | Onpattro |
| Kci USA, INC. | $18.63 | 2020 | |
| Ardelyx, INC. | $17.32 | 2023 | Ibsrela |
| Biogen, INC. | $17.19 | 2024 | Spinraza |
| Alkermes, INC. | $16.88 | 2024 | Vivitrol |
| Promius Pharma LLC | $15.90 | 2019 | |
| Cmp Pharma, INC. | $15.32 | 2021 | |
| Optos, INC. | $15.29 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Supernus Pharmaceuticals, INC. | $15.29 | 2019 | Xyosted |
| Tolmar, INC. | $14.09 | 2023 | |
| Philips North America LLC | $13.89 | 2020 | |
| Gilead Sciences, INC. | $13.29 | 2019 | |
| Assertio Therapeutics, INC. | $13.14 | 2020 |
Drugs and devices associated with these payments
Repatha $47KInnovamatrix Ac $34KNexletol $5,438Nexlizet $5,119Nuzyra $4,698Rexulti $2,112Airsupra $896Fanapt $788Caplyta $775Ozempic $774Vraylar $773Kerendia $749Otezla $742Voquezna $649Gemtesa $641Auvelity $635Nurtec Odt $627Zavzpret $522Qulipta $482Nucala $480Farxiga $456Nayzilam $391Austedo Xr $381Tremfya $371Ingrezza $363Ubrelvy $341Verquvo $333Abilify Maintena $330Sunosi $297Wegovy $271Veozah $252Dupixent $246Abilify Asimtufii $233Leqvio $227Kerecis Surgiclose $198Azstarys $195Cobenfy $182Briviact $173Trelegy Ellipta $172Tezspire $168Freestyle Libre 3 $168Gvoke Hypopen $164Xyosted $157Flumist Quadrivalent $149Xifaxan $143Mounjaro $142Rybelsus $134Daxxify $131Accrufer $126Linzess $111Lokelma $111Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap $102Trudhesa $101Dexcom G7 Gss (161) $101Dexcom Stelo Glucose Biosensor $101Simponi Aria $100Paxlovid $92.26Dexcom G6 Transmitter $88.27Korlym $85.19Viberzi $84.55Mavyret $82.76Belsomra $80.87Entresto $73.92Creon $73.08Nuplazid $65.67Aplenzin $65.40Evenity $65.24Eliquis $62.89Ilet Bionic Pancreas $62.76Uzedy $57.07Omnipod $56.59Spravato $55.81Fasenra $53.75Cologuard Collection Kit $50.86Seglentis $49.64Kerecis Graftguide $49.46Natroba $48.99Spinosad $48.99Synthroid $48.87Prolia $47.37Symbravo $47.34Relistor $45.51Zepbound $43.29Comirnaty $42.99Aptiom $41.68Ajovy $40.46Puraply $38.12Enbrel $35.46Urgok2 $34.52Nuedexta $34.28Tzield $30.97Panoramic Ophthalmoscope $30.58Oct Ophthalmoscope $30.58Austedo $26.84Ofev $24.65Tonmya $24.54Tlando $23.46Nocdurna $23.46Xarelto $23.30Ohtuvayre $22.54
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.